Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.59 -0.02 (-3.28%)
At close: Oct 22, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Receivables - Net (2025 - 2026)

Updated

Rani Therapeutics Holdings (RANI) recorded Receivables - Net of $2.04 million in Q2 2026, unchanged from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Receivables - Net (2025 - 2026) Analysis & Trends

Starting with Q1 2025, Rani Therapeutics Holdings' Receivables - Net history includes 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Rani Therapeutics Holdings 110.43 Mn -381,884.91 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.04 Mn
Mar 31, 2026 2.04 Mn
Dec 31, 2025 2.04 Mn
Mar 31, 2025 600,000.00
API Access

Rani Therapeutics Holdings Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=RANI&period=max&api_key=YOUR_API_KEY